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in echocardiography should be the responsibility of the direc- 
tor of the echocardiographic training laboratory and the 
director of the cardiology training program. 
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Training in Nuclear Cardiology 
Nuclear cardiology methods (Table 1) provide important 
diagnostic and prognostic information with which all modern 
cardiologists hould be conversant. Training for cardiology 
fellows should be divided into three levels:t 
*The recommendations of this task force were developed jointly with the 
American Society of Nuclear Cardiology and will be published inthe Journal of 
Nuclear Cardiology. These recommendations were approved by the Board of 
Directors of the Society. 
tThe issues of ongoing clinical competence and training or retraining of
practicing cardiologists are beyond the scope of this document. However, it 
should be noted that hese issues are currently being addressed bythe American 
Society of Nuclear Cardiology (ASNC). For additional information, contact 
ASNC at 9111 Old Georgetown Road, Bethesda, Maryland 20814. 
1. General training (2 months) for all cardiology fellows is 
designed to make the fellow conversant with the field of 
nuclear cardiology (level 1). 
2. Specialized training (4 to 6 months) for fellows who wish to 
have special expertise in clinical nuclear cardiology and 
practice nuclear cardiology (level 2). 
3. Advanced training (1 year) for trainees who wish to pursue 
an academic direction in nuclear cardiology, including 
patient care, teaching and research (level 3). 
Training should include the study of the indications for 
specific nuclear cardiology tests and proper clinical application 
of the diagnostic information derived from the appropriate 
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test. Independent interpretation fnuclear studies, followed by 
integration of test results with other clinical and laboratory 
data, is desirable. This training should be acquired in an 
Accreditation Council for Graduate Medical Education 
(ACGME) approved program in either cardiology, nuclear 
medicine or radiology. The preceptor should ensure that a 
logbook or other specific records document cases and didactic 
training hours in which the fellow has participated. In the case 
of the advanced trainee, specialized training and research can 
be derived as a part of an established program either in 
cardiology or in a division of nuclear medicine; the preceptor 
for specialized or advanced training should have level 3 (or the 
equivalent) raining in nuclear cardiology. 
General Training--Level 1 (2-Month Minimum) 
The trainee should be exposed to the fundamentals of 
nuclear cardiology for a period of two months during the 
fellowship. This two month experience should provide expo- 
sure to nuclear medicine technology and practice su~ticient for 
the clinical practice of adult cardiology, but not for the practice 
of nuclear cardiology. 
Background. To have an adequate understanding of the 
clinical applications of nuclear cardiology and to perform the 
test safely, the physician trainee must acquire knowledge of or 
proficiency in, or both, the following areas: 
1. Coronary angiography and dynamics 
2. Cardiac hemodynamics 
3. Cardiac pathophysiology 
4. Rest and exercise lectrocardiography 
5. Exercise physiology 
6. Pharmacology of standard cardiovascular d ugs 
7. Cardiopulmonary esuscitation and treatment of other car- 
diac emergencies 
8. Pharmacology and physiology of commonly used stress 
agents, such as dipyridamole, adenosine and dobutamine 
9. Clinical outcomes assessment 
Didactic program. Interpretation of radionuclide studies. 
During their 2-month rotation, fellows should actively partici- 
pate in daily radionuclide study interpretation (minimum of 
80 h) under the direction of a qualified individual in nuclear 
cardiology. For all studies in which angiographic or hemody- 
namic data, or both, are available, such information should be 
correlated with the radionuclide studies. Studies should in- 
clude one or more of the following: 
1. Myocardial (perfusion) imaging with exercise and redistribu- 
tion, rest or reinjection studies, or both, or pharmacologic 
stress using qualitative and quantitative analysis. 
2. Radionuclide angiography using the gated equilibrium or 
"first-pass" approach, or both. 
3. An established teaching file of both perfusion and ventric- 
ular function studies with angiographic/cardiac catheteriza- 
tion documentation f disease should be available in each 
program. 
Ideally, experience in all of these aspects of nuclear cardi- 
ology is recommended. Nevertheless, in institutions that em- 
phasize certain procedures, an adequate background for gen- 
eral fellowship training in nuclear cardiology can be satisfied 
with less diversified training. 
Lectures and reading in nuclear cardiology. The second 
component of the didactic program should consist of lectures 
on the basic aspects of nuclear cardiology and parallel reading 
material. The lectures and reading should provide the fellow 
with an outline of the applications of nuclear cardiology, 
including positron emission tomography (PET). Specificity, 
sensitivity, diagnostic accuracy, utility in assessing prognosis 
and interventions, costs, indications and pitfalls must be em- 
phasized for each patient subset. Such information could be 
effectively transmitted within a weekly noninvasive conference 
or catheterization conference during which the radionuclide 
imaging data are presented. 
Knowledge and appreciation of radiation safety. The third 
component of the didactic program should provide the fellow 
with an appreciation of radiation safety as it relates to admin- 
istration of radiopharmaceuticals. 
Hands-on experience. Fellows should perform complete 
nuclear cardiology studies alongside the qualified technologist 
or other qualified personnel. They should observe and then 
participate under qualified supervision i  the following proce- 
dures: preparation, calibration and administration of the 
radiopharmaceutical dose; treadmill, bicycle and pharmaco- 
logic stress testing, alone or in combination; utilization of the 
electrocardiographic gating device; basic operation and quality 
control of the gamma camera; operation of the imaging 
computer system for acquisition, image processing and appro- 
priate display. This should include adequate xperience in 
stress myocardial perfusion, radionuclide angiography (rest or 
exercise, or both; equilibrium or "first pass," or both); and 
miscellaneous procedures. 
Specialized Training--Level 2 (4 to 6 Months) 
Fellows who wish to practice the specialty of clinical nuclear 
cardiology should be required to have at least 4 to 6 months of 
total training. In training institutions with a high volume of 
nuclear cardiology procedures, clinical experience may be 
acquired in a period of time as short as 4 months. In institu- 
tions with a lower volume of procedures, a total of 6 months of 
clinical experience will be necessary for level 2 competency. 
This additional training should be dedicated to enhancing 
clinical skills and qualifying for Nuclear Regulatory Commis- 
sion (NRC) licensure. The details of NRC licensure require- 
ments are listed in the Appendix. 
Didactic program. Appropriate radiation safety training 
(currently 200 h [see Appendix]) should be provided to satisfy 
NRC licensure requirements. The training should provide 
fellows with a series of lectures and laboratories dealing with 
basic radiation physics, radiation protection, radiopharmaceu- 
tical chemistry, radiation biology and instrumentation accord- 
ing to NRC requirements. This program might be scheduled 
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Table 1. Classification fNuclear Cardiology Procedures 
1. Standard nuclear cardiology procedures 
a. Myocardial (perfusion) imaging rest/exercise/pharmacologic 
(planar/SPECT) 
b. Gated equilibrium or "first-pass" radionuclide cineangiography 
(rest/exercise) 
2. Less common uclear cardiology procedures 
a. Myocardial infarction imaging 
b. Metabolic imaging (i.e., PET) 
c. Shunt studies 
PET = positron emission tomography; SPECT - single-photon emission 
computed tomography. 
Table 2. Summary of Training Requirements for 
Nuclear Cardiology 
Level Total Duration of Training Total No. of Examinations 
1 2 mo (80 h interpretative 
experience) 
2 4-6 mo (minimum of 300* 
200 h radiation safeW) 
3 12 mo (minimum of 200 h 600* 
radiation safety,) 
*A minimum of 50 cases must be performed and interpreted under 
supervision. The remaining supervised interpretative experience can be obtained 
from a teaching file. 
over a 12- to 24-month period concurrent with other fellowship 
assignments. 
Clinical experience. The fellow should participate in inter- 
pretation of all nuclear cardiology imaging data for the 4- to 
6-month training period. During the course of the 4- to 6- 
month training period, it is imperative that the fellow have 
experience in correlating catheterization/angiographic data 
with radionuclide-derived data in a minimum of 30 patients. A
teaching conference in which the fellow presents the clinical 
material and scintigraphic results is an appropriate forum for 
such an experience. Another appropriate source of interpreta- 
tive experience can consist of an established teaching file. For 
level 2 training, a total of 300 cases should be interpreted 
under supervision, either from direct patient studies or from 
the teaching file, consisting of diverse types of procedures 
(Table 1). Minutes or a written logbook should be kept; cases 
and diagnoses should also be listed to provide documentation. 
Hands-on experience. Fellows acquiring level 2 training 
should have additional hands-on experience with patient stud- 
ies. Additional intensive experience should be acquired in a 
minimum of 50 patients; optimally 25 patients for myocardial 
(perfusion) imaging and 25 patients for radionuclide angiog- 
raphy (total 50 patients). Such supervised experience should 
include pretest patient evaluation, radiopharmaceutical prep- 
aration (including experience with relevant radionuclide gen- 
erators), performance ofthe study (rest, exercise dipyridamole 
or adenosine or other pharmacologic stress), administration of
the dosage, calibration and setup of the gamma camera, setup 
of the imaging computer and processing the data for display 
after acquisition. 
Additional experience. In addition, the training program 
must provide experience in computer methods for analysis of 
perfusion imaging studies, including single-photon emission 
computed tomography (SPECT), and ejection fraction and 
regional wall motion measurements from radionuclide angio- 
graphic studies. 
Evaluation. Both the person responsible for the nuclear 
cardiology training program and the program director should 
also be responsible for evaluating the competence of the 
trainee in nuclear cardiology at the completion of the program. 
This can be accomplished by observing the performance of the 
fellow during the daily reading sessions or by a formal testing 
procedure, or both. 
Advanced Training--Level 3 (Minimum of 1 Year) 
For fellows who wish to pursue an academic areer in 
nuclear cardiology or to direct a nuclear cardiology laboratory, 
an extended program is required. This can be part of the 
standard 3-year cardiology fellowship. In addition to the 
recommended program for level 2, this program should in- 
clude active participation in ongoing laboratory or clinical 
research, or both, with individual responsibility for a segment 
of that research. In parallel with participation in a research 
program, the trainee should participate in clinical imaging 
activities for the total training period of _>12 months, to 
include supervised interpretative xperience in 600 cases. 
Hands-on experience should be similar to or greater than that 
required for the clinical practitioner (level 2). The fellow 
should be trained in most of the following areas: 
• Qualitative interpretation of standard nuclear cardiology 
studies, including myocardial (perfusion) imaging, gated 
equilibrium studies, "first-pass" and infarct imaging studies 
• Quantitative analysis of perfusion or metabolic studies 
• Quantitative radionuclide angiographic analyses, including 
measurement of global and regional ventricular function 
• SPECT studies 
• PET studies (see later) when available. 
The same method of evaluation of proficiency as indicated in 
level 2 should be applied. 
The overall requirements for training in general nuclear 
cardiology are summarized in Table 2. 
Specific Training in Cardiac Positron 
Emission Tomography 
Cardiac PET is part of nuclear cardiology but is technically 
different and not widely available. Nevertheless, at this time, 
for institutions that have PET, training guidelines are appro- 
priate. Training in this particular imaging technology should go 
hand-in-hand and may be concurrent with training in conven- 
tional nuclear cardiology but should include those aspects that 
are unique or specific to PET. Depending on the desired level 
of expertise, training in cardiac PET should include knowledge 
of substrate metabolism in the normal and diseased heart; 
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knowledge of positron emitting tracers for blood flow, metab- 
olism and neuronal activity, medical cyclotrons, radioisotope 
production and radiotracer synthesis; and principles of tracer 
kinetics and their in vivo application for the noninvasive 
measurements of regional metabolic and functional processes. 
The training should also include the physics of positron decay, 
aspects of imaging instrumentation specific to PET, production 
of radiopharmaceutical agents, quality control, handling of 
ultrashort-life radioisotopes, appropriate radiation protection 
and safety and regulatory aspects. 
Consistent with the training guidelines for general nuclear 
cardiology, training should be divided into three classes. 
General Training (2 Months) 
This level is for cardiology fellows, in an institution where 
PET is available, who wish to become conversant with cardiac 
PET. Training should therefore be the same as for level 1 
training in nuclear cardiology but should include aspects 
specific to cardiac PET. The additional proficiency to be 
acquired by physician trainees includes background in sub- 
strate metabolism, patient standardization and problems re- 
lated to diabetes mellitus and lipid disorders, positron emitting 
tracers of flow and metabolism and technical aspects of PET 
imaging. A didactic program should include interpretation of
cardiac PET studies of myocardial blood flow and substrate 
metabolism, diagnostic accuracy and cost-effectiveness of via- 
bility assessment and coronary artery disease detection and 
appreciation of radiation safety as specifically related to PET. 
Hands-on experience should include supervised observation 
and interpretation of cardiac PET studies. 
Specialized Training (Total 4 to 6 Months) 
This level of training is for fellows who wish to perform and 
interpret cardiac PET studies in addition to nuclear cardiology. 
This training should include all level 1 and 2 training in nuclear 
cardiology (4 to 6 months) as well as general training for 
cardiac PET. Specific aspects of training for PET should 
include radiation dosimetry, radiation protection and safety, 
dose calibration, handling of large doses of high energy 
radioactive material of short physical half-lives, quality assur- 
ance procedures and NRC safety and record keeping require- 
ments. This level of training requires direct patient experience 
with a minimum of 40 patient studies of myocardial perfusion 
or metabolism, or both. 
Advanced Training (Minimum 1 Year) 
This level of training is intended for those cardiologists who 
wish to direct a cardiac PET laboratory or to pursue an 
academic areer in cardiac PET. Similar to level 3 training in 
nuclear cardiology, this training should include active partici- 
pation in laboratory and clinical research in parallel with 
clinical activities. 
In addition to the requirements for general and specialized 
cardiac PET training (including standard nuclear cardiology 
training, as previously described), advanced training should 
include the following: 
1. Basic principles of cyclotrons, isotope production, radiosyn- 
thesis, tracer kinetic principles and tracer kinetic models, 
cardiac innervation and receptors and methods for quanti- 
fying regional myocardial blood flow and substrate metab- 
olism. 
2. Image acquisition and processing (sinograms, errors in 
image reconstruction, correction routines for photon atten- 
uation, patient misalignment). 
3. Tissue kinetics of positron emitting tracers; in vivo applica- 
tion of tracer kinetic principles; tracer kinetic models, 
generation of tissue time activity curves and computer- 
assisted calculation of region of functional processes of the 
myocardium. 
4. Computer-assisted data manipulation, quantitative image 
analysis and image display. 
Appendix 
The following are the current Nuclear Regulatory Commission (NRC) 
requirements for licensure to perform nuclear cardiologic studies, as 
quoted directly from the Federal Register. It is the intent of the 
American College of Cardiology training uides that fellows complet- 
ing level 2 training should be eligible for NRC licensure according to 
the following NRC rules (1):* 
Training for Imaging and Localization Studies 
Except as provided in §35.970 or §35.971, the licensee shall require 
the authorized user of a radiopharmaceutical, generator reagent kit 
in §35.200(a) to be a physician who 
a. Is certified in 
1. nuclear medicine by the American Board of Nuclear Medicine; 
2. diagnostic radiology by the American Board of Radiology; or 
3. diagnostic radiology or radiology by the American Osteopathic 
Board of Radiology; or 
b. has had classroom and laboratory training in basic radioisotope 
handling techniques applicable to the use of prepared radiophar- 
maceuticals, generators and reagent kits, supervised work experi- 
ence and supervised clinical experience as follows: 
1. 200 h of classroom and laboratory training that includes 
i. radiation physics and instrumentation; 
ii. radiation protection; 
iii. mathematics pertaining to the use and measurement of
radioactivity 
iv. radiopharmaceutical chemistry; and 
v. radiation biology; and 
2. 500 h of supervised work experience under the supervision of an 
authorized user that includes 
*Some "agreement" s ates, by agreement with the NRC, have their own 
licensing requirements, which may differ from those of the NRC. For details. 
contact the American Society of Nuclear Cardiology. 
JACC Vol. 25, No. 1 JOSEPHSON ET AL. 23 
January 1995:1-34 TASK FORCE 6 
i. ordering, receiving and unpacking radioactive materials 
safely and performing the related radiation surveys; 
ii. calibrating dose calibrators and diagnostic instruments and 
performing checks for proper operation ofsurvey meters; 
iii. calculating and safely preparing patient dosages; 
iv. using administrative controls to prevent the misadministra- 
tion of by-product material; 
v. using procedures to contain spilled by-product material 
safely and using proper decontamination procedures; and 
vi. eluting technetium-99m from generator systems, measuring 
and testing the eluate for molybdenum-99 and alumina 
contamination and processing the eluate with reagent kits to 
prepare technetium-99m-labeled radiopharmaceuticals; and 
3. 500 h of supervised clinical experience under the supervision f 
an authorized user that includes 
i. examining patients and reviewing their case histories to 
determine their suitability for radioisotopic diagnosis, limi- 
tations or contraindications; 
ii. selecting the suitable radiopharmaceuticals and calculating 
and measuring the dosages; 
iii. administering dosages topatients and using syringe radiation 
shields; 
iv. collaborating with the authorized user in the interpretation 
of radioisotope t st results; and 
v. patient follow-up; or 
c. Has successfully completed a 6-month training program in 
nuclear medicine that has been approved by the Accreditation 
Council for Graduate Medical Education and that included 
classroom and laboratory training, work experience and super- 
vised clinical experience in all the topics identified in paragraph 
b of this section. 
Reference 
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Task Force 6: Training in Specialized Electrophysiology, Cardiac 
Pacing and Arrhythmia Management 
MARK E. JOSEPHSON, MD, FACC, Co-CHAIRMAN, JAMES D. MALONEY,  MD, FACC, Co-CHAIRMAY, 
S. SERGE BAROLD, MD, FACC, NANCY C. FLOWERS, MD, FACC, 
NORA F. GOLDSCHLAGER,  MD, FACC, DAVID L. HAYES, MD, FACC, 
ERIC N. PRYSTOWSKY, MD, FACC 
Clinical cardiac electrophysiology and cardiac pacing have 
matured significantly and are merging into a common cardiac 
subspecialty discipline. Today, complex cardiac arrhythmias 
are managed by cardiologists and cardiac surgeons with special 
expertise in cardiac electrophysiology, the use of implantable 
pacemakers and cardioverter-defibrillators and the application 
of other interventional techniques and treatments. Nonphar- 
macologic therapy also includes electrophysiologic mapping 
and subsequent catheter or surgical ablation as standard 
treatment for certain tachyarrhythmias. Many new antiarrhyth- 
mic agents with diverse mechanisms of action are often used 
therapeutically alone or in conjunction with implantable mul- 
tiprogrammable arrhythmia control devices (pacemakers and 
implantable cardioverter-defibrillators). 
In 1986, Task Force VI, Training in Cardiac Pacing, and 
Task Force VII, Training in Arrhythmias and Specialized 
Electrophysiologic Studies and Interventions, were published 
separately as a result of the Bethesda Conference 17 on adult 
cardiology training. The present task force combines these two 
closely related disciplines to reflect the current merging of 
science, art and practice of clinical cardiac electrophysiology. 
Genera l  S tandards  and Env i ronment  
General Standards, Facilities and Faculty 
Three organizations, the American College of Cardiology 
(ACC), American Heart Association (AHA) and The North 
American Society of Pacing and Electrophysiology (NASPE), 
have recently addressed training requirements and guidelines 
for pacemaker implantation (1), guidelines for use of implant- 
able cardioverter-defibrillators in cardiovascular p actice (2), 
training requirements for permanent pacemaker selection, 
implantation and follow-up (3) and teaching objectives for 
fellowship programs in clinical electrophysiology (4,5). The 
